Isis Pharmaceuticals (ISIS)

Add to Watchlists Create an Alert
20.98 +0.34  +1.65%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Isis Pharmaceuticals Cash from Operations Quarterly:

-10.58M for March 31, 2013
View Full Chart

Isis Pharmaceuticals Cash from Operations Quarterly Chart

    Isis Pharmaceuticals Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -10.58M
    Dec. 31, 2012 36.04M
    Sept. 30, 2012 -24.87M
    June 30, 2012 -2.577M
    March 31, 2012 -6.711M
    Dec. 31, 2011 -22.74M
    Sept. 30, 2011 -23.17M
    June 30, 2011 -26.18M
    March 31, 2011 -39.84M
    Dec. 31, 2010 -25.50M
    Sept. 30, 2010 -21.43M
    June 30, 2010 5.03M
    March 31, 2010 -21.69M
    Dec. 31, 2009 -31.36M
    Sept. 30, 2009 -32.26M
    June 30, 2009 -10.43M
    March 31, 2009 -34.40M
    Dec. 31, 2008 -19.18M
    Sept. 30, 2008 -21.55M
    June 30, 2008 177.64M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    ISIS Cash from Operations Quarterly Benchmarks

    Companies
    Aegerion Pharmaceuticals -21.48M
    Sanofi
    Biogen Idec 178.94M

    ISIS Cash from Operations Quarterly Rankings

    Overall 44th percentile
    4217 of 7600
    Sector 24th percentile
    491 of 653 in Healthcare
    Industry 34th percentile
    156 of 238 in Biotechnology

    ISIS Cash from Operations Quarterly Range, Past 5 Years

    Minimum -39.84M Mar 2011
    Maximum 177.64M Jun 2008
    Average -7.787M